Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab

Clinical trial NCT03982992 · WITHDRAWN

Trial details

NCT number: NCT03982992
Sponsor: Ludwig-Maximilians - University of Munich
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell Transplantation B-Cell Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia in Remission Acute Lymphoblastic Leukemia, Adult

Start date: 2019-06-01
Primary completion: 2021-05-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.